Preliminary Assessment of Vascular Electrical Stimulation Therapy for Acute Vaso-Occlusive Crisis in Patients With Sickle Cell Disease

Interventional, prospective, randomized, comparative, monocentric study of sickle cell disease patients with Vascular Electrical Stimulation Therapy for treatment of vaso-occlusive crises

Status

Active, not recruiting

Phases

Unknown

Study type

Interventional

Source

PACTR

Registry ID

PACTR201610001807329

Enrollment

Registered

2016-10-04

Start date

2016-11-01

Completion date

Unknown

Last updated

2026-08-03

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Haematological Disorders sickle cell disease

Interventions

VEST Patients

Control patients

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: Patients with sickle cell anemia (HbSS), hemoglobin SC (HbSC), or HbS-¿-thalassemia (HbS-¿thal) who are experiencing uncomplicated severe acute VOC (score of ¿6 cm on a 10-cm visul analog scale [VAS])

Exclusion criteria

Exclusion criteria: Patients carrying a cardiac pacemaker Pregnancy VOC concomitant with other acute processes including acute chest syndrome and potential serious infection. Regular smoking Transfusion within the last 30 days

Design outcomes

Primary

Measure	Time frame
Change in pain score using VAS test	—

Secondary

Measure	Time frame
Pain score using VAS test;Narcotic uptake	—

Countries

Burkina Faso

Contacts

Public ContactEtienne L'Hermite

Public relation

elhermite@diavein.com+41 21 791 11 10

Outcome results

None listed

Source: PACTR (via WHO ICTRP) · Data processed: Aug 9, 2026